| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-16 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-15 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |